Walleye Trading
MDGL icon

Walleye Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Walleye Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
478
+397
+490% +$203K ﹤0.01% 3010
2026
Q1 		$42.4K Sell
81
-133
-62% -$63.5K ﹤0.01% 3723
2025
Q4 		$125K Buy
+214
New +$109K ﹤0.01% 3643
2022
Q4 		– Sell
-3,936
Closed -$385K – 5224
2022
Q3 		$256K Buy
+3,936
New +$273K ﹤0.01% 3487
2022
Q2 		– Sell
-1,601
Closed -$118K – 5452
2022
Q1 		$157K Sell
1,601
-919
-36% -$77.5K ﹤0.01% 3979
2021
Q4 		$214K Buy
+2,520
New +$207K ﹤0.01% 3800
2020
Q4 		– Sell
-1,600
Closed -$190K – 4801
2020
Q3 		$190K Buy
1,600
+1,515
+1,782% +$164K ﹤0.01% 3027
2020
Q2 		$10K Buy
+85
New +$8.36K ﹤0.01% 4073
2018
Q4 		– Sell
-46
Closed -$10K – 5034
2018
Q3 		$10K Buy
+46
New +$11.5K ﹤0.01% 4989
2015
Q4 		– Sell
-246
Closed -$15K – 5510
2015
Q3 		$15K Buy
+246
New +$17.8K ﹤0.01% 4212

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Walleye Trading's MDGL Position: Q2 2026 in Review

Walleye Trading increased its Madrigal Pharmaceuticals (MDGL) stake by 490% in Q2 2026, buying an estimated $203K and bringing the position to 478 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #3010.

Walleye Trading first reported a position in MDGL in Q3 2015 and has held it in 10 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Walleye Trading held 478 shares of Madrigal Pharmaceuticals worth $257K as of Q2 2026.
  • Walleye Trading bought 397 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $203K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3010 holding.
  • Walleye Trading first reported a position in Madrigal Pharmaceuticals in Q3 2015 and has held it in 10 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.